TrialBritish journal of cancer2018

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.

Astrid Lipplaa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.